A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma
贝伐珠单抗联合高剂量干扰素α-2B治疗转移性黑色素瘤的II期临床试验
期刊:Journal of Immunotherapy
影响因子:2.9
doi:10.1097/CJI.0b013e31821dcefd
Grignol, Valerie P; Olencki, Thomas; Relekar, Kiran; Taylor, Cynthia; Kibler, Amanda; Kefauver, Cheryl; Wei, Lai; Walker, Michael J; Chen, Helen X; Kendra, Kari; Carson, William E 3rd